Research Article | Open Access
Asma M. Elsharif, Tamer E. Youssef, Suhailah S. Al-Jameel, Hanan H. Mohamed, Mohammad Azam Ansari, Suriya Rehman, Sultan Akhtar, "Synthesis of an Activatable Tetra-Substituted Nickel Phthalocyanines-4(3H)-quinazolinone Conjugate and Its Antibacterial Activity", Advances in Pharmacological and Pharmaceutical Sciences, vol. 2019, Article ID 5964687, 10 pages, 2019. https://doi.org/10.1155/2019/5964687
Synthesis of an Activatable Tetra-Substituted Nickel Phthalocyanines-4(3H)-quinazolinone Conjugate and Its Antibacterial Activity
The aim of this study was to synthesize a series of nickel(II)phthalocyanines (NiPcs) bearing four 4(3H)-quinazolinone ring system units, (qz)4NiPcs 4a–d. The electronic factors in the 4(3H)-quinazolinone moiety that attached to the NiPc skeleton had a magnificent effect on the antibacterial activity of the newly synthesized (qz)4NiPcs 4a–d against Escherichia coli. The minimum MICs and MBCs value were recorded for compounds 4a, 4b, 4c, and 4d, respectively. The results indicated that the studied (qz)4NiPcs 4a–d units possessed a broad spectrum of activity against Escherichia coli. Their antibacterial activities were found in the order of 4d > 4c > 4b > 4a against Escherichia coli, and the strongest antibacterial activity was achieved with compound 4d.
To date, a great variety of phthalocyanines (Pcs) derivatives functionalized with substituted heterocycles such as pyridyloxy, 4-pyridylmethyloxy, and N-methyl morpholiniumethoxy substituents have received attention as antibacterial agents [1–3]. The antimicrobial properties of various derivatives of phthalocyanines such as zinc phthalocyanine-silver nanoparticle conjugates , octacationic zinc phthalocyanines bearing 1,2-ethanediamine groups and the quaternized derivatives , pentalysine β-carbonylphthalocyanine zinc , and silicon phthalocyanine  against Gram-negative and Gram-positive bacteria and biofilm-forming bacteria have been reported by the researchers. 4(3H)-Quinazolinones are known to possess interesting drugs with diverse biological activities. They were used to modify the biological properties of several other compounds. The major effective biological activities and pharmacological properties of their derivatives include analgesic , anticonvulsant , antidiabetic [10, 11], antitubercular and antibacterial effects , antihypertensive , antiviral , and cancer chemotherapy .
Earlier, Youssef and Hanack have described novel symmetrically and asymmetrically NiPcs bearing heterocyclic moieties for pharmaceutical application , in connection with a previous work and our current interest in the synthesis of Pcs derivatives functionalized with substituted heterocycles for biological evaluations [17, 18]. We described herein a facile convenient synthesis of novel tetra-substituted nickel phthalocyanines based on the heterocyclic moiety (i.e., 4(3H)-quinazolinone ring system (qz)4NiPcs (4a–d)). However, antibacterial properties of tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives have not been yet explored. To the best of our knowledge, this is the first report which aims to modify the structural activity of nickel(II)phthalocyanines conjugate with four 4(3H)-quinazolinone units and evaluate their parameters required for the structure-function relationship for antibacterial properties. The antibacterial activity results obtained for the newly formed (qz)4NiPcs 4a–d show promising antibacterial properties against Escherichia coli.
2. Materials and Methods
All reagents and solvents were used without further purification. 4-Nitrophthalonitrile, 2-methyl-4(3H)-quinazolinone, 2-phenyl-4(3H)-quinazolinone, 2-(trifluoromethyl)-4(3H)-quinazolinone, and 2-mercapto-4(3H)-quinazolinone were purchased commercially from Aldrich and used as received. All solvents (GR grade) from Merck (Darmstadt, Germany) were distilled. Silica gel thin-layer chromatography (TLC) plates of 250 microns from Analtech (Newark, DE, USA) were used.
Melting points were uncorrected and determined by the open capillary method. IR spectra were recorded on a Nicolet Magna 560 spectrophotometer with spectral range 4000–400 cm−1. 1H-NMR spectra were recorded in dimethyl sulfoxide (DMSO) using a BVT 3000 Bruker Spectro spin instrument operating at 300.13 MHz. UV-Vis spectra were recorded in dimethyl formamide (DMF) using an Agilent 8453 UV-Vis spectrophotometer. Field depolarization mass spectroscopy technique (FDMS) mass spectra were recorded using a Varian MAT 711A spectrometer and reported in mass/charge (m/z). The electron ionization technique (EIMS) operated at 70 eV and reported in mass/charge (m/z). The Carlo Erba elemental analyzer 1106 was used to perform elementary analyses. Thin layer chromatography (TLC) on precoated silica gel plates was used to determine the purity of all synthesized compounds utilizing different eluents with different ratios as developing solvent systems. The morphological features of as-synthesized tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives were examined before and after the bacteria treatment by scanning electron microscopy (SEM). The synthesized powder was also examined by transmission electron microscopy (TEM) in order to analyze the structure of the material with high resolution. SEM (FEI, ISPECT S50, Czech Republic) was operated at 20 kV, and TEM (FEI, Morgagni, Czech Republic) was performed at 80 kV. The electronic micrographs were recorded at 30 kx (SEM) and 180 kx (TEM) magnifications to obtain the representative features of the specimens. For SEM, the samples were mounted on a metallic stub with a double-sided adhesive tape and applied a thin layer of gold using sputter coating machine (Quorum, Q150R ES, UK) to minimize the less conductive nature of the material from charging. For TEM, powder was dispersed in ethanol, sonicated for 5–7 minutes, and deposited onto TEM grid. TEM grids were air-dried and mounted into the TEM.
2.1. Typical Procedure for Synthesis of 4(3H)-Quinazolinone-phthalonitrile Precursors 3a–d
A mixture of 4-nitrophthalonitrile 1 (4.4 mg, 2.6 mmol) and quinazolinone derivatives 2a–d, (4.4 mg, 2.75 mmol) 2a, (5.7 mg, 2.5 mmol) 2b, (4.2 mg, 2.4 mmol) 2c, (4.3 mg, 2.4 mmol) 2d, was dissolved in dry DMF (70 mL) and then stirred for 40 min at room temperature. A finely grounded K2CO3 (excess) was added portionwise over 4 hours and then stirred for 24 h at 75–80°C. The mixture was cooled to room temperature. It was poured into ice water. The crude product was held at 2.5 h and filtered off, and the mixture washed with water and dried under vacuum. The crude products were purified by column chromatography (silica gel, dichloromethane/n-hexane) in different ratios (9 : 1/8 : 2 v/v), yielding 5.5 mg (78%) of the pure phthalonitrile 3a, 6.1 mg (70%) of 3b, 5.0 mg (69%) of 3c, and 4.8 mg (70%) of 3d.
2.1.1. Synthesis of 2-Methyl-4(3H)-quinazolinone-phthalonitrile 3a
Prepared from 2-methyl-4(3H)-quinazolinone (2a) as a white solid; m.p. 291–292°C; IR (KBr): = 3071–3069 (Ar-Hstr), 2966, 2869 (C-Hstr, CH3), 2233 (CNstr), 1678 (C=Ostr, qz ring), 1658 (C-N; C-C); 1586, 1570, 1480 (C–CH); 1421 mPh, 1419, 855, 742, 746 d(C–C), 644, 521 cm−1. 1H-NMR (DMSO-d6): δ = 1.55 (3H, s, CH3-qz), 7.7–7.9 (4H, m, Ar-H, quinazolinone moiety), 8.24 (1H, dd, 5-H), 8.38 (1H, d, 6-H), 8.40 (1H, s, 3-H) ppm. MS (EI): m/z = 286.29 (M+). Elemental analysis: C17H10N4O found C 70.97, H 3.19, N 19.11, Calcd. C 71.32, H 3.52, N 19.57.
2.1.2. Synthesis of 2-Phenyl-4(3H)-quinazolinone-phthalonitrile 3b
Prepared from 2-phenyl-4(3H)-quinazolinone (2b) as a white solid; m.p. 311–314°C; IR (KBr): = 3071–3066 (Ar-Hstr), 2960, 2872 (C-Hstr, CH3), 2238 (CNstr), 1680 (C=Ostr, qz ring), 1664 (C-N; C-C); 1581, 1575, 1483 (C–CH); 1429 mPh, 1421, 855, 740, 750 d(C–C), 640, 521 cm−1. 1H-NMR (DMSO-d6): δ = 7.2–7.5 (4H, m, Ar-H, quinazolinone moiety), 8.10 (1H, dd, 5-H), 8.26 (1H, d, 6-H), 8.37 (1H, s, 3-H), 8.55 (5H, m, ph-qz) ppm. MS (EI): m/z = 348.36 (M+). Elemental analysis: C22H12N4O, Found C 70.97, H 3.87, N 18.98, Calcd. C 71.32, H 3.52, N 19.57.
2.1.3. Synthesis of 2-Trifluoromethyl-4(3H)-quinazolinone-phthalonitrile 3c
Prepared from 2-trifluoromethyl-4(3H)-quinazolinone (2c), as a white solid; m.p. 270–272°C; IR (KBr): = 3060–3068 (Ar-Hstr), 2970, 2874 (C-Hstr, CH3), 2590 (SHstr), 2230 (CNstr), 1677 (C=Ostr, qz ring), 1668 (C-N; C-C); 1584, 1578, 1470 (C–CH); 1427 mPh, 1412, 853, 745, 748 d(C–C), 646, 530 cm−1. 1H-NMR (DMSO-d6): δ = 7.3–7.6 (4H, m, Ar-H, quinazolinone moiety), 8.49 (1H, dd, 5-H), 8.56 (1H, d, 6-H), 8.68 (1H, s, 3-H) ppm. MS (EI): m/z = 340.26 (M+). Elemental analysis: C17H7N4OF3, Found C 60.61, H 2.57, N 14.71, Calcd. C 60.01, H 2.07, N 14.01.
2.1.4. Synthesis of 2-Mercapto-4(3H)-quinazolinone-phthalonitrile 3d
Prepared from 2-mercapto-4(3H)-quinazolinone (2d), as a white solid; m.p. 287–290°C; IR (KBr): = 3066–3070 (Ar-Hstr), 2968, 2871 (C-Hstr, CH3), 2597 (SHstr), 2230 (CNstr), 1677 (C=Ostr, qz ring), 1666 (C-N; C-C); 1581, 1575, 1470 (C–CH); 1427 mPh, 1411, 851, 746, 743 d(C–C), 648, 530 cm−1. 1H-NMR (DMSO-d6): δ = 3.30 (1H, s, SH-qz), 7.3–7.6 (4H, m, Ar-H, quinazolinone moiety), 8.41 (1H, dd, 5-H), 8.54 (1H, d, 6-H), 8.64 (1H, s, 3-H) ppm. MS (EI): m/z = 304.33 (M+). Elemental analysis: C16H8N4OS, found C 62.87, H 2.07, N 19.11, Calcd. C 63.15, H 2.65, N 18.41.
2.2. Typical Procedure for Synthesis of Tetra [4(3H)-Quinazolinone]phthalocyaninatonickel(II), [(qz)4NiPcs] (4a–d)
A solution of 4(3H)-quinazolinone-phthalonitrile derivative 3a–d (5.5 mg, 2.04 mmol) 3a, (6.3 mg, 2.08 mmol) 3b, (6.6 mg, 2.05 mmol) 3c, (7.2 mg, 2.04 mmol) 3d and nickel(II) acetate dihydrate (0.22 g, 0.09 mmol) in 15 mL of n-pentanol. The mixture was stirred for 20 min under argon atmosphere. DBU (6 mL, 0.07 mmol) was added, and the mixture was refluxed for 30 h at 140–145°C. It was cooled at room temperature and then precipitated with methanol (10 mL). The solid was filtered and then washed with water and dried under vacuum. The crude products were purified by column chromatography (silica gel, chloroform/n-hexane) in different ratios (9 : 1/8 : 2 v/v), yielding 18 mg (75%) of the pure NiPc 4a, 21 mg (72%) of 4b, 18 mg (73%) of 4c, and 14 mg (70%) of 4d.
2.2.1. Synthesis of Tetra [2-Methyl-4(3H)-quinazolinone]phthalocyaninatonickel(II), [(Me-qz)4NiPc] (4a)
IR (KBr): = 3074–3069 (Ar-Hstr), 2977, 2878 (C-Hstr, CH3), 1673 (C=Ostr, qz ring), 1660 (C-N; C-C); 1582, 1579, 1470 (C–CH); 1413 mPh, 1411, 858, 740, 748 d(C–C), 644, 528 cm−1. 1H-NMR (DMSO-d6): δ = 1.33–1.7 (12H, m, CH3-qz), 7.4–7.8 (16H, m, Ar-H, quinazolinone moiety), 8.40 (4H, dd, 5-H), 8.55 (4H, d, 6-H), 8.62 (4H, s, 3-H) ppm. UV-vis (DMF): λmax (nm): 670, 625, 356 sh, 294 nm. MS (FD): m/z = 1203.84 (M+). Elemental analysis: C68H40N16O4Ni, Found C 68.01, H 3.87, N 18.97, Calcd. C 67.84, H 3.35, N 18.62.
2.2.2. Synthesis of Tetra [2-Phenyl-4(3H)-quinazolinone]phthalocyaninatonickel(II), [(Ph-qz)4NiPc] (4b)
IR (KBr): = 3074–3065 (Ar-Hstr), 2977, 2872 (C-Hstr, CH3), 1675 (C=Ostr, qz ring), 1653 (C-N; C-C); 1578, 1573, 1475 (C–CH); 1440 mPh, 1404, 852, 740, 745 d(C–C), 649, 525 cm−1. 1H-NMR (DMSO-d6): δ = 7.2–7.5 (16H, m, Ar-H, quinazolinone moiety), 8.03 (4H, dd, 5-H), 8.15 (4H, d, 6-H), 8.36 (4H, s, 3-H), 8.5–8.8 (20H, m, ph-qz) ppm. UV-vis (DMF): λmax (nm): 682, 620, 352 sh, 258 nm. MS (FD): m/z = 1452.12 (M+). Elemental analysis: C88H48N16O4Ni, Found C 66.93, H 3.64, N 19.03, Calcd. C 72.79, H 3.33, N 15.43.
2.2.3. Synthesis of Tetra [2-Trifluoromethyl-4(3H)-quinazolinone]phthalocyaninatonickel(II), [(CF3-qz)4NiPc] (4c)
IR (KBr): = 3072–3070 (Ar-Hstr), 2974, 2872 (C-Hstr, CH3), 1680 (C=Ostr, qz ring), 1665 (C-N; C-C); 1578, 1578, 1479 (C–CH); 1442 mPh, 1410, 853, 745, 748 d(C–C), 649, 523 cm−1. 1H-NMR (DMSO-d6): δ = 7.4–7.7 (16H, m, Ar-H, quinazolinone moiety), 8.21 (4H, dd, 5-H), 8.36 (4H, d, 6-H), 8.56 (4H, s, 3-H) ppm. UV-vis (DMF): λmax (nm): 688, 614, 330 sh, 290 nm. MS (FD): m/z = 1419.73 (M+). Elemental analysis: C68H28N16O4F12Ni, Found C 57.01, H 2.05, N 16.08, Calcd. C 57.53, H 1.99, N 15.79.
2.2.4. Synthesis of Tetra [2-Mercapto-4(3H)-quinazolinone]phthalocyaninatonickel(II), [(SH-qz)4NiPc] (4d)
IR (KBr): = 3072–3070 (Ar-Hstr), 2974, 2875 (C-Hstr, CH3), 1680 (C=Ostr, qz ring), 1654 (C-N; C-C); 1578, 1573, 1478 (C–CH); 1442 mPh, 1403, 855, 742, 749 d(C–C), 648, 524 cm−1. 1H-NMR (DMSO-d6): δ = 3.40 (4H, s, SH-qz), 7.4–7.7 (16H, m, Ar-H, quinazolinone moiety), 8.30 (4H, dd, 5-H), 8.40 (4H, d, 6-H), 8.62 (4H, s, 3-H) ppm. UV–vis (DMF): λmax (nm): 690, 618, 335 sh, 292 nm. MS (FD): m/z = 1276 (M+). Elemental analysis: C64H32N16O4S4Ni, Found C 59.06, H 2.06, N 16.97, Calcd. C 60.42, H 2.53, N 17.56.
2.3. Characterization of Antibacterial Activity of Tetra-Substituted 4(3H)-Quinazolinone Nickel(II)phthalocyanine Derivatives
Escherichia coli was chosen to investigate the antibacterial properties of tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives, and then E. coli cultures were grown overnight in nutrient broth in a shaking incubator (200 rpm) at 37°C. Its bacterial culture was then washed 2-3 times with phosphate-buffered saline. The Escherichia coli suspensions were diluted with sterile 0.9% NaCl solution to reach concentrations of approximately 107 CFU/ml.
2.4. Minimal Inhibitory Concentration (MIC)
The antibacterial activity of tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives was assessed using the standard agar dilution method [19, 20]. The MIC was determined on MHA plates using serial dilutions of tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives in concentration range from 32 to 1 mg/ml. The MIC is the lowest concentration of compounds at which no visible growth of the bacteria was seen [19, 20].
2.5. Minimal Bactericidal Concentration (MBC)
The MIC plates which have no growth were further selected for MBC assessment . Then, 100 μl 0.9% normal saline was added onto the MIC plates and then transferred to another freshly prepared MHA plate without supplementing with tested compounds. They incubated it at 37°C for 24 h . The lowest concentration of tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives at which no growth of bacterial cells has been found or less than three CFUs have been present were recorded as MBC [19, 20].
2.6. Effect of Tetra-Substituted 4(3H)-Quinazolinone Nickel(II)phthalocyanine Derivatives on the Morphology of Escherichia coli
Further, the effects of tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives on the morphology of Escherichia coli cells were investigated by scanning electron microscope as previously reported . Briefly, ∼106 CFU/ml of Escherichia coli cells treated with tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives was incubated at 37°C overnight. After incubation, the treated and untreated bacterial cells were centrifuged at 12000 rpm for 10 min. The pellets were washed with PBS and fixed with 2.5% glutaraldehyde followed by 1% osmium tetroxide. After washing, samples were dehydrated by a series of ethanol . The cells were fixed on the aluminum stubs, then dried in a desecrator, and coated with gold. Finally, samples were examined at an accelerating voltage of 20 kV by SEM.
Advanced synthetic procedure for the newly nickel(II)phthalocyanines (qz)4NiPcs 4a–d substituted by 4(3H)-quinazolinone units has been described. Phthalonitrile derivatives 3a–d were used by a two-step reaction procedure depicted in Figure 1. A nucleophilic ipso-nitro substitution reaction of 4-nitrophthalonitrile 1 was carried out with 4(3H)-quinazolinone derivatives 2a–d in dry DMF for 24 h at 75–80°C. Following this, cyclotetramerization reaction of 4(3H)-quinazolinone-phthalonitriles precursors 3a–c with Ni(II)acetate in the presence of DBU as organic base in n-pentanol for 30 h at 140–145°C afforded the corresponding (qz)4NiPcs (4a–d) with 71–74% yield. The desired phthalocyanines were separated chromatographically as a mixture of regioisomers from the reaction mixture (Figure 1).
The described synthetic method produced a mixture of four regioisomers with a 4(3H)-quinazolinone units at the 2 or 3 positions of each benzene ring in the (qz)4NiPc molecule. The formation of constitutional isomers [21, 22] and the high-dipole moment that results from the 4(3H)-quinazolinone units at the periphery positions leads to increase the solubility of the obtained products 4a–d.
The 1H-NMR spectra of tetra-substituted nickel(II)phthalocyanines 4a–d were obtained as expected. The 1H-NMR spectrum of (Me-qz)4NiPc 4a indicated the methyl protons at δ = 1.30–1.6 ppm and the aromatic protons of Pc skeleton at 7.38 ppm. Also, the 1H-NMR spectrum of (Ph-qz)4NiPc 4b indicated the aromatic protons of phenyl group at δ = 8.5–8.8 ppm. In case of (SH-qz)4NiPc 4d, thiol proton appeared at δ = 3.38 ppm (see Section 2.2).
The electronic spectra of the studied nickel(II)phthalocyanines (qz)4NiPcs 4a–d measured in DMF showed characteristic absorption bands in the Q band region at around 670, 682, 688, and 690 nm, respectively. The B-bands were observed at around 356, 352, 330, and 335 nm, respectively (Figure 2).
SEM and TEM are commonly used tools to explore the microstructure of the materials. Figure 3 shows the SEM micrographs of the phthalocyanines derivative products: control, additive of phenyl ring, trifluoro groups, and sulfur atoms. It was seen that the morphology of the product was completely altered with the addition of phthalocyanine derivatives. The pure phthalocyanines complex (Figure 3(a)) exhibited the fibrous-like structure compacted in bundle-shaped structure of varying sizes, sub-micrometer to few micrometer ranges. Phenyl and trifluoro groups-additive phthalocyanine derivatives (Figures 3(b) and 3(c)) showed the continuous but porous morphology, whereby fibrous bundles disappeared as seen in the pure phthalocyanines matrix. Phthalocyanines with sulfur also showed the porous morphology, but the surface of the complex was smooth compared to other specimens (Figure 3(d)).
The structure of the phthalocyanines complexes was further investigated by TEM for high resolution (Figure 4). By TEM, it can be seen that all derivatives showed the porous structure of phthalocyanines but the porosity level and the morphology of the product vary for different complexes. The control specimen showed the sponge-like structure with pores from few nanometers to tens of nanometers (Figure 3(a)). The trifluoro-additive phthalocyanines product displayed the regular sized pore structure with pore size under 100 nm (Figure 4(c)). On the other hand, the sulfur-additive complex exhibited pores with material having a particle-alike structure, and the average size of the particles was estimated around 50 nm.
In the present study, antibacterial properties of tetra-substituted 4(3H)-quinazolinone nickel (II)phthalocyanine derivatives against Escherichia coli ATCC 25922 have been evaluated by determining MICs and MBCs using agar dilution methods. The MICs and MBCs values of tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives 4a, 4b, 4c, and 4d are summarized in Table 1. The minimum MIC and MBC value recorded were 4 and 8 mg/ml for compound 4d, whereas compounds 4c, 4b, and 4a showed MICs values of 8, 8, and >16 and MBCs values of 16, 16, and >32 mg/ml, respectively. The antibacterial activities were found in the order of 4d > 4c > 4b > 4a against Escherichia coli, and the strongest antibacterial activity was achieved with compound 4d (Table 1).
The morphological and structural changes in Escherichia coli cells caused by tetra-substituted 4(3H)-quinazolinone nickel (II)phthalocyanine derivatives were further investigated by SEM. The untreated (control) Escherichia coli cells were typically rod-shaped, intact, and normal having regular and smooth cell surface (Figure 5(a)).
However, Escherichia coli cells treated with tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives (4a, 4b, 4c and 4d) were not intact, i.e., the cells were abnormal in shape with irregular fragments appeared at the cell surfaces (Figures 5(b), 5(c), 6, and 7). The bacterial cells treated with compound 4a were almost similar to that of control cells and no obvious alteration has been observed at a concentration of 8 mg/ml (Figure 5). The Escherichia coli cells treated with compounds 4b and 4c showed mild alternation in the morphology of cells at 4 mg/ml (Figure 6). However, E. coli cells treated with compound 4d show significant alternation at a concentration of 4 mg/ml (Figure 7(b)).
Further, it has been observed that as the concentration of compound 4d increases, it was noticed that the Escherichia coli cells were severely damaged because of formation of pits, indentation, deformation, and distortion of cell wall and membrane, indicating significant loss of the integrity of the cell membrane that may possibly lead to bacterial cell death (Figures 6(b)–6(d)). From the results, we suggested that the attachments of tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanine derivatives to bacterial cell surface may play an important role in achieving good bactericidal activity.
There is very few information available in the literature regarding the mode of action of phthalocyanine derivatives against bacteria, but previous report on phthalocyanine derivatives suggested that singlet oxygen formed and ROS generated by phthalocyanine derivatives possibly interact with bacterial cell membrane that may damage the membrane integrity due to increased cell permeability and leakage of the intracellular materials [1, 4, 5].
The present study reports the successful synthesis of the title nickel(II)phthalocyanine (qz)4NiPcs 4a–d in good yields. The results indicated that the studied (qz)4NiPcs 4a–d possessed an activity against Escherichia coli. A preliminary study of the structure-activity relationship revealed that electronic factors in the 4(3H)-quinazolinone moiety that attached to the pc molecule has a great effect on the antibacterial activity of these nickel(II)phthalocyanines. The antibacterial activities were found in the order of 4d > 4c > 4b > 4a against Escherichia coli, and the strongest antibacterial activity was achieved with compound 4d.
|(qz)4NiPcs:||Tetra-substituted 4(3H)-quinazolinone nickel(II)phthalocyanines|
|E. coli:||Escherichia coli.|
The data used to support the findings of this study are included within the article.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
The authors acknowledge the National Research Centre (NRC), Giza, Egypt, for supporting this work.
- P. Mikula, L. Kalhotka, D. Jancula et al., “Evaluation of antibacterial properties of novel phthalocyanines against Escherichia coli—comparison of analytical methods,” Journal Photochemistry and Photobiology B: Biololgy, vol. 138, pp. 230–239, 2014.
- D. Jolanta, S. Wojciech, K. Tomasz, S.-M. Paulina et al., “Antimicrobial and anticancer photodynamic activity of a phthalocyanine photosensitizer with N-methyl morpholiniumethoxy substituents in nonperipheral positions,” Journal Inorganic Biochemistry, vol. 172, pp. 67–79, 2017.
- U. Canan, D. Naciye, Ö. Yetkin, Y. Burcu Turanl et al., “A novel of PEG-conjugated phthalocyanine and evaluation of its photocytotoxicity and antibacterial properties for photodynamic therapy,” Journal Porphyrins and Phthalocyanines, vol. 21, no. 01n03, pp. 10–24, 2018.
- N. Rapulenyane, E. Antunes, and T. Nyokong, “A study of the photophysicochemical and antimicrobial properties of two zinc phthalocyanine–silver nanoparticle conjugates,” New Journal of Chemistry, vol. 37, no. 4, pp. 1216–1223, 2013.
- M. Li, B. Mai, A. Wang et al., “Photodynamic antimicrobial chemotherapy with cationic phthalocyanines against Escherichia coli planktonic and biofilm cultures,” RSC Advances, vol. 7, no. 65, pp. 40734–40744, 2017.
- Z. Chen, S. Zhou, J. Chen et al., “An effective zinc phthalocyanine derivative for photodynamic antimicrobial chemotherapy,” Journal of Luminescence, vol. 152, pp. 103–107, 2014.
- M. Dimaano, C. Rozario, M. Nerandzic, C. Donskey, M. Lam, and E. Baron, “The photodynamic antibacterial effects of silicon phthalocyanine (Pc) 4,” International Journal of Molecular Sciences, vol. 16, no. 12, pp. 7851–7860, 2015.
- K. Hemalatha and K. Girija, “Synthesis of some novel 2,3 disubstituted quinozolinone derivatives as analgesic and antinflammatory agents,” International Journal Pharmaceutical Science, vol. 3, no. 2, pp. 103–106, 2011.
- G. Hanan, A.-G. Nagwa, and A. Safinaz, “Synthesis and anticonvulsant activity of some quinazolin-4-(3H)-one derivatives,” Molecules, vol. 13, no. 10, pp. 2557–2569, 2008.
- J. Rudolph, W. P. Esler, S. O’Connor et al., “Quinazolinone derivatives as orally available ghrelin receptor antagonists for the treatment of diabetes and obesity,” Journal of Medicinal Chemistry, vol. 50, no. 21, pp. 5202–5216, 2007.
- H. Leila, A. Alireza, R. Mohsen, S. Hamid, and M. Khajouei, “Synthesis and cytotoxic evaluation of some new 3-(2-(2-phenylthiazol-4-yl) ethyl)-quinazolin-4(3H) one derivatives with potential anticancer effects,” Research Pharmaceutical Science, vol. 12, no. 4, pp. 290–298, 2017.
- J. Soňa, S. Štefan, and Š. Katarína, “In vitro antibacterial activity of ten series of substituted quinazolines,” Biologia Bratislava, vol. 59, no. 6, pp. 741–752, 2004.
- D. J. Connolly, D. Cusack, T. P. O’Sullivan, and P. J. Guiry, “Synthesis of quinazolinones and quinazolines,” Tetrahedron, vol. 61, no. 43, pp. 10153–10202, 2005.
- M. Dinakaran, P. Selvam, E. DeClercq, and S. K. Sridhar, “Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted-4(3H)-quinazolinones,” Biological & Pharmaceutical Bulletin, vol. 26, no. 9, pp. 1278–1282, 2003.
- A. Kamal, E. Vijaya Bharathi, M. Janaki Ramaiah et al., “Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: design, synthesis and biological evaluation as potential anticancer agents,” Bioorganic & Medicinal Chemistry, vol. 18, no. 2, pp. 526–542, 2010.
- T. E. Youssef and M. Hanack, “Asymmetrically fused heterocyclic phthalocyaninato nickel(II) adducts: synthesis and characterization,” Journal of Porphyrins and Phthalocyanines, vol. 9, no. 1, pp. 28–31, 2005.
- T. E. Youssef, Y. ALhamed, and S. AL-Sharani, “Antitumor activity of tetra-substituted zinc phthalocyanines containing 4(3H)-quinazolinone derivatives,” Revista de Chimie (Bucharest), vol. 65, pp. 560–564, 2014.
- S. S. Al Jameel and T. E. Youssef, “Investigations on the antitumor activity of classical trifluoro-substituted zinc phthalocyanines derivatives,” World Journal Microbiology and Biotechnology, vol. 34, no. 4, pp. 1–7, 2018.
- M. A. Ansari, H. M. Khan, A. A. Khan, A. Sultan, and A. Azam, “Synthesis and characterization of the antibacterial potential of ZnO nanoparticles against extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated from a tertiary care hospital of North India,” Applied Microbiology and Biotechnology, vol. 94, no. 2, pp. 467–477, 2012.
- A. M. M. Essa, M. A. Al Abboud, and S. I. Khatib, “Metal transformation as a strategy for bacterial detoxification of heavy metals,” Journal of Basic Microbiology, vol. 58, no. 1, pp. 17–29, 2018.
- T. E. Youssef and M. Hanack, “Synthesis and characterization of unsymmetrically substituted dienophilic nickel phthalocyanines for Diels-Alder reactions,” Journal of Porphyrins and Phthalocyanines, vol. 6, no. 9, pp. 571–577, 2002.
- B. Helmut, K. Venkata, T. E. Youssef, and M. Hanack, “Structural investigations of hexadecafluoro(phthalocyaninato)ruthenium(II) F16PcRu with EXAFS spectroscopy,” Journal Porphyrins and Phthalocyanine, vol. 15, no. 07n08, pp. 598–601, 2011.
Copyright © 2019 Asma M. Elsharif et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.